Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Expression of the cell cycle regulators p14(ARF) and p16(INK4a) in chronic myeloid leukemia.

Authors: Cividin, M  Ayrault, O  Sorel, N  Seite, P  Brizard, F  Blanchet, O  Mahon, FX  Guilhot, F  Larsen, C  Chomel, JC  Brizard, A 
Citation: Cividin M, etal., Leuk Res. 2006 Oct;30(10):1273-8. Epub 2006 Mar 14.
Pubmed: (View Article at PubMed) PMID:16533530
DOI: Full-text: DOI:10.1016/j.leukres.2006.02.002

Expression of p14(ARF) and p16(INK4a) tumor suppressor genes was investigated in 109 patients with chronic myeloid leukemia (CML). The p14(ARF) and p16(INK4a) mRNA levels were significantly low in patients in chronic phase (CP) at presentation and high in patients treated with interferon-alpha (IFN-alpha), especially in non-responders. A moderate overexpression of p14(ARF) with a normal expression of p16(INK4a) was observed in imatinib-resistant patients. Although protein expression did not consistently match mRNA levels, a role for the two cell cycle regulators in the IFN-alpha signaling pathway is suggested as well as a relation with the resistance to IFN-alpha or imatinib therapy.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 11251777
Created: 2016-06-22
Species: All species
Last Modified: 2016-06-22
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.